investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Adult vs. Fetal Programs in Leukemia Pathogenesis
Andrew Weng
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew Weng
BC Cancer Agency
Vancouver, Canada
Related projects
Peter C Adamson
COG NCTN Network Group Operations Center
Leukaemia
Pediatric oncology or childhood cancer
Susan L Slager
Genetic Epidemiology Of Chronic Lymphocytic Leukemia
Leukaemia
Pathology
Richard E Champlin
The Therapy of Chronic Myeloid Leukemia (CML)
Leukaemia
Pathology
Robert M Williams
Multiple Myeloma and Cancer Therapies via Largazole Analogs
Leukaemia
Pathology
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Pathology
Gregory Armstrong
Childhood Cancer Survivor Study
Leukaemia
Pediatric oncology or childhood cancer
Richard Aplenc
Genetic Predictors of AML Treatment Response
Leukaemia
Pediatric oncology or childhood cancer
Aaron D Schimmer
Targeting Mitochondrial Protein Synthesis with Tigecycline for the Treatment of l
Leukaemia
Pathology
Thomas J O'Hare
Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia
Leukaemia
Pathology
